v3.26.1
Reverse Recapitalization (Details) - USD ($)
12 Months Ended
Dec. 22, 2025
Oct. 29, 2025
Mar. 31, 2025
Feb. 28, 2025
Feb. 11, 2025
Dec. 31, 2025
Dec. 31, 2024
Reverse Recapitalization [Line Items]              
Share converted (in Shares)           501,140  
Common stock exchange ratio           2,159.47-for-1  
Reclassified additional paid-in capital           $ 279,746
Aggregate purchase price of private placement           $ 7,161,504
Warrants Quantity           2,605,832  
Maximum offering amount sold   $ 4          
Total cash commission           10.00%  
Non-allocable expense allowance           2.00%  
Percentage of common stock equal to warrant           10.00%  
Common stock, share issued (in Shares) [1]           8,655,829 3,249,999
Warrant to purchase shares (in Shares)           132,570  
Equity issuance costs           $ 1,683,523 $ 193,876
Net proceeds $ 582,961            
Conversion price (in Dollars per share)           $ 3.3  
Common stock at an exercise price (in Dollars per share)           3.3  
Common stock at an exercise price (in Dollars per share)           $ 4.4  
Debt issuance costs           $ 197,570  
Derivative liabilities           551,269  
Reacquisition price           1,681,166  
Fair value of warrants           6,312 17,087
Gain on extinguishment           326,345 $ (194,537)
Private Adaptin’s Exchange Notes [Member]              
Reverse Recapitalization [Line Items]              
Net proceeds           $ 1,500,000  
Secured Promissory Notes [Member]              
Reverse Recapitalization [Line Items]              
Secured promissory notes issued           10.00%  
2024 Convertible Debt [Member]              
Reverse Recapitalization [Line Items]              
Secured promissory notes issued           10.00%  
Conversion of Exchange Notes and 2024 Notes [Member]              
Reverse Recapitalization [Line Items]              
Debt amount           $ 2,007,510  
Principal amount           1,500,000  
Accrued interest           $ 153,811  
A Warrant [Member]              
Reverse Recapitalization [Line Items]              
Warrants Quantity         1    
Exercise price (in Dollars per share)         $ 4.4    
Warrant term         1 year    
B Warrant [Member]              
Reverse Recapitalization [Line Items]              
Warrant term         5 years    
Placement Agent Warrants [Member]              
Reverse Recapitalization [Line Items]              
Warrant term           4 years 4 months 24 days  
Warrant to purchase shares (in Shares)           350,086  
Warrant [Member]              
Reverse Recapitalization [Line Items]              
Warrant to purchase shares (in Shares)           2,100,513  
Fair value of warrants           $ 247,906  
Unite Acquisition 1 Corp. [Member]              
Reverse Recapitalization [Line Items]              
Share converted (in Shares)         3,249,999    
Lucius Partners LLC [Member]              
Reverse Recapitalization [Line Items]              
Common stock retained (in Shares)         3,250,000    
Share cancel and retire (in Shares)         1,750,000    
Private Placement [Member]              
Reverse Recapitalization [Line Items]              
Private placement offering issued (in Shares)         1,080,814    
Aggregate purchase price of private placement         $ 4,755,582    
Per share price (in Dollars per share)         $ 4.4    
Private Placement [Member] | B Warrant [Member]              
Reverse Recapitalization [Line Items]              
Exercise price (in Dollars per share)         $ 6.6    
Maximum Offering [Member]              
Reverse Recapitalization [Line Items]              
Private placement offering issued (in Shares)     319,528        
Maximum offering amount sold       $ 8.5      
Aggregate purchase price     $ 1,405,923        
Common Stock [Member]              
Reverse Recapitalization [Line Items]              
Aggregate purchase price of private placement $ 1,000,000            
Number of shares in a unit (in Shares)         1    
Common stock, share issued (in Shares)           1,400,342  
Gross proceeds           $ 6,161,505  
Equity issuance costs           1,460,361  
Net proceeds           4,701,144  
Fair value of warrants           $ 1,433,259  
Common Stock [Member] | Private Placement [Member]              
Reverse Recapitalization [Line Items]              
Private placement offering issued (in Shares) 200,000            
Per share price (in Dollars per share) $ 5            
[1] The number of shares and per share value of the Company’s common stock have been retroactively recast to reflect the exchange ratio pursuant to the Merger (see Note 3).